← FDA DRUG APPROVALS

FDA NDA · NDA013664

GANTANOL

Sponsor: ROCHE

APPLICATION
NDA013664
TYPE
NDA
ORIGINAL APPROVAL
1965-07-01
LATEST ACTION
1997-01-09
ROUTE
ORAL
DOSAGE FORM
SUSPENSION
MARKETING STATUS
Discontinued

Products

GANTANOLDiscontinued
SULFAMETHOXAZOLE 500MG/5ML · SUSPENSION · ORAL

Approval history

1997-01-09Labeling · Supplement 19AP
1997-01-09Labeling · Supplement 20AP
1978-01-05Labeling · Supplement 18AP
1965-07-01Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →